Related Experiment Videos
Sequence-specific DNA strand cleavage by 111In-labeled peptide nucleic acids
Yujian He1, Igor G Panyutin, Alex Karavanov
1Department of Nuclear Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892-1180, USA.
European Journal of Nuclear Medicine and Molecular Imaging
|February 6, 2004
Summary
Peptide nucleic acids labeled with indium-111 offer a promising approach for targeted gene therapy. These PNA oligomers effectively damage DNA sites, showing higher efficiency than radiolabeled DNA for potential radiotherapy applications.
Area of Science:
- Biochemistry
- Molecular Biology
- Radiochemistry
Background:
- Peptide nucleic acids (PNAs) exhibit high affinity and sequence specificity for nucleic acids.
- PNAs are being explored for gene-targeted radiotherapeutics to deliver localized radiodamage.
- Developing methods to incorporate radionuclides into PNAs is crucial for their therapeutic potential.
Purpose of the Study:
- To develop a method for incorporating the Auger electron-emitting radionuclide indium-111 into PNA oligomers.
- To evaluate the efficiency of PNA-directed cleavage of single-stranded DNA targets.
- To compare the DNA damaging efficacy of (111)In-labeled PNAs with (111)In-labeled DNA oligomers.
Main Methods:
- Conjugation of diethylene triamine penta-acetic acid (DTPA) to PNA and DNA oligomers.
- Chelation of DTPA-conjugated PNA and DNA with (111)In(3+) to create radiolabeled probes.
- In vitro assessment of PNA-directed DNA strand cleavage by (111)In decay.
Main Results:
- (111)In-labeled PNA-DTPA conjugates induced highly localized DNA strand cleavage in single-stranded DNA targets.
- The yield of DNA strand breaks generated by (111)In decay was 5-7% for PNA-DTPA compared to ≤2% for DNA-DTPA.
- The yield of DNA strand breaks per nuclear decay was approximately 0.1 for PNA-directed delivery, three times higher than for DNA-directed delivery.
Conclusions:
- (111)In-labeled PNAs are significantly more effective than radiolabeled DNA oligonucleotides for site-specific DNA damage.
- PNA oligomers demonstrate potential as efficient radionuclide delivery vehicles for antisense/antigene radiotherapy.
- This study supports the advancement of PNA-based radiotherapeutics for clinical trials.